CymitQuimica logo
CDK

CDK

Gli inibitori delle chinasi ciclina-dipendenti (CDK) sono composti che bloccano l'attività delle CDK, un gruppo di chinasi proteiche che regolano il ciclo cellulare, la trascrizione e altri processi cellulari. Le CDK vengono attivate legandosi alle cicline e la loro attività è cruciale per la progressione delle cellule attraverso le diverse fasi del ciclo cellulare. Inibire le CDK può bloccare la divisione cellulare, portando all'arresto del ciclo cellulare e all'apoptosi, in particolare nelle cellule tumorali in cui le CDK sono spesso disregolate. Gli inibitori delle CDK sono ampiamente utilizzati nella ricerca sul cancro e hanno un potenziale terapeutico nel trattamento di vari tipi di cancro. Presso CymitQuimica, offriamo una selezione completa di inibitori delle CDK di alta qualità per supportare la tua ricerca sul controllo del ciclo cellulare, sul cancro e sullo sviluppo terapeutico.

Trovati 522 prodotti di "CDK"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • PROTAC CDK9 degrader 4

    CAS:
    <p>PROTAC CDK9 degrader 4 is a CDK9 degrader that targets transcriptional regulation and has potential anticancer activity.</p>
    Formula:C43H56N10O5
    Colore e forma:Solid
    Peso molecolare:792.97
  • CDK9 inhibitor HH1

    CAS:
    <p>CDK9 inhibitor HH1 (8019-9719) is an inhibitor of the human CDK2-cyclin A2 complex with an IC50 value of 2 μM.</p>
    Formula:C13H15N3OS
    Purezza:99.92%
    Colore e forma:Solid
    Peso molecolare:261.34
  • Multi-target kinase inhibitor 2


    Compound 5K (Multi-target kinase inhibitor 2) is a multi-targeted kinase inhibitor demonstrating activity against EGFR, Her2, VEGFR2, and CDK2 with IC50 values
    Purezza:98%
    Colore e forma:Odour Solid
  • CDK2/PIM1-IN-1


    <p>CDK2/PIM1-IN-1 is an inhibitor of the kinases CDK2 (IC50: 0.27 μM) and PIM1 (IC50: 0.67 μM). It can induce apoptosis (cell death) and reduce the expression of TNF-α, which promotes tumors. CDK2/PIM1-IN-1 exhibits antitumor activity.</p>
    Colore e forma:Odour Solid
  • CDK12/13-IN-2


    <p>CDK12/13-IN-2 (Compound 24) is a covalent inhibitor of CDK12 and CDK13, exhibiting IC50 values of 15.5 nM and 12.2 nM, respectively. It effectively inhibits the proliferation of breast cancer cells and can be utilized in the research of triple-negative breast cancer.</p>
    Formula:C24H22FN7O2
    Colore e forma:Solid
    Peso molecolare:459.48
  • JH-XVI-178

    CAS:
    JH-XVI-178: potent CDK8/19 inhibitor with good pharmacokinetics, low clearance, moderate oral bioavailability.
    Formula:C22H22ClN7O
    Colore e forma:Solid
    Peso molecolare:435.92
  • FDA-Approved Kinase Inhibitor Library


    <p>A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.</p>
    Colore e forma:Liquid
  • EGFR/CDK2-IN-4


    EGFR/CDK2-IN-4 (compound 4c) is a dual inhibitor targeting EGFR and CDK-2, demonstrating IC50 values of 89.6 nM for EGFR and 165.4 nM for CDK-2.
    Formula:C24H16N6OS2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:468.55
  • CDK2-IN-43


    CDK2-IN-43 (Compound 3a) is a CDK2-cyclin E2 inhibitor with an IC50 value of 6.0 nM. It is applicable to cancer research.
    Formula:C19H27N7O
    Colore e forma:Solid
    Peso molecolare:369.464
  • Kinase Inhibitor Library


    <p>A unique collection of 2720 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;</p>
    Colore e forma:Odour Solid
  • dCeMM3 

    CAS:
    <p>dCeMM3 is a glue degrader that induces ubiquitination and degradation of cyclin K by promoting CDK12-cyclin K interaction with CRL4B ligase.</p>
    Formula:C14H11ClN4OS
    Purezza:98.48% - 99.41%
    Colore e forma:Solid
    Peso molecolare:318.78
  • Cell Cycle Compound Library


    <p>A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);</p>
    Colore e forma:Odour Solid
  • [pSer2, pSer5, pSer7]-CTD TFA


    <p>Substrate '[pSer2, pSer5, pSer7]-CTD (TFA)' for CDK7 phosphorylates RNA Pol II CTD at ser2, 5, 7.</p>
    Formula:C98H138F3N21O39
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:2291.25
  • PP-C8


    PP-C8: PROTAC CDK12-Cyclin K degrader with DC50s 416/412 nM; synergizes with PARP inhibitor against TNBC.
    Formula:C43H51FN12O7
    Colore e forma:Solid
    Peso molecolare:866.94
  • (E/Z)-THZ1 2HCl

    CAS:
    <p>THZ1 2HCl: selective CDK7 allosteric inhibitor, IC50 3.2 nM, hinders cancer cell growth.</p>
    Formula:C31H30Cl3N7O2
    Purezza:99.51%
    Colore e forma:Solid
    Peso molecolare:638.98
  • Cdk2/Cyclin Inhibitory Peptide I


    CDK2, a Ser/Thr kinase, is akin to yeast cdc28 and human Cdk1, crucial for cell division.
    Formula:C111H196N48O23
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:2571.05
  • CDK8-IN-12

    CAS:
    CDK8-IN-12: selective CDK8 inhibitor (Ki 14 nM), oral anticancer, blocks GSK-3α/β, PCK-θ, halts MV4-11 cell growth.
    Formula:C21H20ClN3O2
    Purezza:98.55% - 99.22%
    Colore e forma:Soild
    Peso molecolare:381.86
  • PROTAC CDK9 degrader-7

    CAS:
    PROTAC CDK9 degrader-7 is a proteolysis-targeting chimera (PROTAC) specifically designed to target and mediate the degradation of Cyclin-Dependent Kinase 9 (
    Formula:C43H50Cl2N8O9
    Colore e forma:Soild
    Peso molecolare:893.81
  • BSJ-04-132


    Selective Cdk4 degrader. Degrades Cdk4 in Molt-4 cells, with no effect on Cdk6 levels. Displays cereblon-dependent degradation.
    Colore e forma:Liquid
  • Men 10376

    CAS:
    <p>Men 10376 is a selective antagonist of tachykinin NK-2 receptor. It has a Ki of 4.4 μM for rat small intestine NK-2 receptor.</p>
    Formula:C57H68N12O10
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:1081.22